Purchases and Sales Made in Q2 2024 in Xeris Biopharma Holdings, Inc. (XERS)
This table provides information about the institutional ownership of Xeris Biopharma Holdings, Inc. (XERS) during Q2 2024. The information is specifically focused on institutions that hold shares of Xeris Biopharma Holdings, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-155K- 86.61% |
$263K - $379K
|
23.9K
$85.6K
|
|
|
Aug 14, 2024
Q2 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-189K- 26.73% |
$321K - $463K
|
518K
$1.85M
|
|
|
Aug 12, 2024
Q2 2024
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-223K- 87.54% |
$380K - $547K
|
31.8K
$114K
|
|
|
Aug 09, 2024
Q2 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-248K- 15.59% |
$421K - $607K
|
1.34M
$4.81M
|
|
|
Aug 14, 2024
Q2 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-733K- 76.93% |
$1.25M - $1.8M
|
220K
$787K
|